Intrinsic Value of S&P & Nasdaq Contact Us

Akoya Biosciences, Inc. AKYA NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.40
+86%

Stock Statistics — AKYA

Akoya Biosciences, Inc. (AKYA) has a market capitalization of $64.44M and trades at $1.29. The 52-week range is 0.931-3.42.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.2, Earnings Per Share (EPS) of $-1.12, annual revenue of $81.67M.

The stock has a beta of 1.35, operates in the Healthcare sector.

Trading Data
Current Price$1.29
52-Week Range0.931-3.42
Volume715.25K
Avg Volume (30D)582.12K
Market Cap$64.44M
Beta (1Y)1.35
Company
IPO Date2021-04-16
Employees205
CEOBrian McKelligon
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS00974H1041
CUSIP00974H104
Income (Latest Year)
Revenue$81.67M
Gross Profit$47.88M
EBITDA$-37.14M
Operating Income$-46.73M
Net Income$-55.37M
EPS$-1.12
EPS Diluted$-1.12
Shares Outstanding$49.42M
Balance Sheet (Latest Year)
Total Assets$125.01M
Current Assets$76.73M
Cash & ST Investments$35.04M
Total Liabilities$117.41M
Total Debt$84.15M
Net Debt$72.37M
Total Equity$7.6M
Debt / Equity11.08
Valuation Ratios
P/E Ratio-1.2
P/S Ratio0.79
P/B Ratio8.48
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message